Larry Michael Mertz

CIK 1938051 · Chief Technology Officer · last filed 2025-04-07

Larry Michael Mertz is a Chief Technology Officer who has filed 12 SEC Form 4 insider transactions across 1 company since 2022. The most recent filing, for AXDX, was dated Apr 7, 2025. Across all open-market trades the lifetime net is +$116.7K, making them a net buyer over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

12

Lifetime Open-Market Net

$116.7K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Accelerate Diagnostics, Inc (AXDX) Delisted Chief Technology Officer 86,326 $0.03 $2.9K $116.7K 12 2025-04-07

Recent Filings

12 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-04-07 Accelerate Diagnostics, Inc (AXDX) Delisted Mixed +2,775 -$990 EDGAR
2024-05-30 Accelerate Diagnostics, Inc (AXDX) Delisted Grant (A) $0 EDGAR
2024-05-21 Accelerate Diagnostics, Inc (AXDX) Delisted Mixed +922 -$318 EDGAR
2024-04-10 Accelerate Diagnostics, Inc (AXDX) Delisted Mixed +26,649 -$12.2K EDGAR
2024-04-05 Accelerate Diagnostics, Inc (AXDX) Delisted Mixed +1,888 -$861 EDGAR
2024-03-06 Accelerate Diagnostics, Inc (AXDX) Delisted Grant (A) $0 EDGAR
2023-06-20 Accelerate Diagnostics, Inc (AXDX) Delisted Grant (A) $0 EDGAR
2023-05-24 Accelerate Diagnostics, Inc (AXDX) Delisted Mixed +9,356 -$2.5K EDGAR
2023-03-06 Accelerate Diagnostics, Inc (AXDX) Delisted Mixed +82,928 -$16.4K EDGAR
2023-02-15 Accelerate Diagnostics, Inc (AXDX) Delisted Grant (A) $0 EDGAR
Showing 110 of 12
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.